D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

BenzingaNov 16 05:55 · Ratings

VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 16 00:52 · Conference Call

VolitionRX | 10-Q: Q3 2024 Earnings Report

SECNov 15 05:29 · Announcements

VolitionRX Q3 2024 GAAP EPS $(0.07), Inline, Sales $474.522K Miss $652.000K Estimate

BenzingaNov 15 05:28

VolitionRX Reports Q3 Results

Seeking AlphaNov 15 05:18

Earnings Scheduled For November 14, 2024

BenzingaNov 14 16:32